222 related articles for article (PubMed ID: 10070880)
1. Analysis of the interaction of monoclonal antibodies with surface IgM on neoplastic B-cells.
Cragg MS; Zhang L; French RR; Glennie MJ
Br J Cancer; 1999 Feb; 79(5-6):850-7. PubMed ID: 10070880
[TBL] [Abstract][Full Text] [Related]
2. The influence of avidity on signaling murine B lymphocytes with monoclonal anti-IgM antibodies. Effects of B cell proliferation versus growth inhibition (tolerance) of an immature B cell lymphoma.
Udhayakumar V; Kumar L; Subbarao B
J Immunol; 1991 Jun; 146(12):4120-9. PubMed ID: 2040794
[TBL] [Abstract][Full Text] [Related]
3. Surface immunoglobulins are involved in the interaction of protein A with human B cells and in the triggering of B cell proliferation induced by protein A-containing Staphylococcus aureus.
Romagnani S; Giudizi MG; Biagiotti R; Almerigogna F; Maggi E; Del Prete G; Ricci M
J Immunol; 1981 Oct; 127(4):1307-13. PubMed ID: 6974188
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of anti-IgM and growth factor-induced proliferation of guinea pig B cells by one of two distinct Fc gamma receptors on the cells.
Yamashita T; Koyama J
J Immunol; 1988 Nov; 141(9):2889-94. PubMed ID: 2971734
[TBL] [Abstract][Full Text] [Related]
5. Cross-linking of B lymphocyte Fc gamma receptors and membrane immunoglobulin inhibits anti-immunoglobulin-induced blastogenesis.
Phillips NE; Parker DC
J Immunol; 1984 Feb; 132(2):627-32. PubMed ID: 6228594
[TBL] [Abstract][Full Text] [Related]
6. The development of anti-CD79 monoclonal antibodies for treatment of B-cell neoplastic disease.
Zhang L; French RR; Chan HT; O'Keefe TL; Cragg MS; Power MJ; Glennie MJ
Ther Immunol; 1995 Aug; 2(4):191-202. PubMed ID: 9358611
[TBL] [Abstract][Full Text] [Related]
7. Activation and proliferation signals in mouse B cells. V.A. comparison of the effects of intact (IgG) and F (ab')2 anti-mu or anti-delta antibodies.
Klaus GG; Bijsterbosch MK; Parkhouse RM
Immunology; 1985 Apr; 54(4):677-83. PubMed ID: 2984110
[TBL] [Abstract][Full Text] [Related]
8. Activation of human B cells and inhibition of their terminal differentiation by monoclonal anti-mu antibodies.
Maruyama S; Kubagawa H; Cooper MD
J Immunol; 1985 Jul; 135(1):192-9. PubMed ID: 3923101
[TBL] [Abstract][Full Text] [Related]
9. Disparate functions of I-A and I-E molecules on B cells as evidenced by the inhibition with anti-I-A and anti-I-E antibodies of polyclonal B cell activation.
Takahama Y; Ono S; Ishihara K; Muramatsu M; Hamaoka T
Eur J Immunol; 1989 Dec; 19(12):2227-35. PubMed ID: 2558020
[TBL] [Abstract][Full Text] [Related]
10. Demonstration of immunoglobulin-related molecules on human peripheral blood T lymphocytes using chicken anti-F(ab')2 and anti-IgM antibodies.
Haegert DG
Immunology; 1980 Nov; 41(3):663-71. PubMed ID: 6161876
[TBL] [Abstract][Full Text] [Related]
11. Antiidiotypic activity in the IgM fractions of mixed cryoglobulins.
Geltner D; Franklin EC; Frangione B
J Immunol; 1980 Oct; 125(4):1530-5. PubMed ID: 6774023
[TBL] [Abstract][Full Text] [Related]
12. Activation of B cells in vivo by a Fab/Fc fragment of a monoclonal anti-IgD antibody requires an interaction between the antibody fragment and a cellular IgG Fc receptor.
Goroff DK; Finkelman FD
J Immunol; 1988 May; 140(9):2919-24. PubMed ID: 2966202
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of human B-cell lymphoma by an anti-CD20 antibody and its chimeric F(ab')2 fragment via induction of apoptosis.
Liu Y; Zheng M; Lai Z; Xiong D; Fan D; Xu Y; Peng H; Shao X; Xu Y; Yang M; Wang J; Liu H; Xie Y; Yang C; Zhu Z
Cancer Lett; 2004 Mar; 205(2):143-53. PubMed ID: 15036646
[TBL] [Abstract][Full Text] [Related]
14. Induction of apoptosis by monoclonal antibody anti-APO-1 class switch variants is dependent on cross-linking of APO-1 cell surface antigens.
Dhein J; Daniel PT; Trauth BC; Oehm A; Möller P; Krammer PH
J Immunol; 1992 Nov; 149(10):3166-73. PubMed ID: 1431095
[TBL] [Abstract][Full Text] [Related]
15. CD19 monoclonal antibody HD37 inhibits anti-immunoglobulin-induced B cell activation and proliferation.
Pezzutto A; Dörken B; Rabinovitch PS; Ledbetter JA; Moldenhauer G; Clark EA
J Immunol; 1987 May; 138(9):2793-9. PubMed ID: 2437199
[TBL] [Abstract][Full Text] [Related]
16. Mitogenicity of anti-Thy-1 monoclonal antibodies attributable to an Fc-dependent mechanism.
Kummer U; Haunschild J; Reisbach G; Delecluse HJ; Thierfelder S
Eur J Immunol; 1993 Oct; 23(10):2649-54. PubMed ID: 8104797
[TBL] [Abstract][Full Text] [Related]
17. Tumour dormancy and cell signalling--III: Role of hypercrosslinking of IgM and CD40 on the induction of cell cycle arrest and apoptosis in B lymphoma cells.
Marches R; Racila E; Tucker TF; Picker L; Mongini P; Hsueh R; Vitetta ES; Scheuermann RH; Uhr JW
Ther Immunol; 1995 Jun; 2(3):125-36. PubMed ID: 8885131
[TBL] [Abstract][Full Text] [Related]
18. Functional studies on B cell hybridomas with B cell surface antigens. I. Effects of anti-immunoglobulin antibodies on proliferation and differentiation.
Hamano T; Asofsky R
J Immunol; 1983 May; 130(5):2027-32. PubMed ID: 6403617
[TBL] [Abstract][Full Text] [Related]
19. Binding to CD20 by anti-B1 antibody or F(ab')(2) is sufficient for induction of apoptosis in B-cell lines.
Cardarelli PM; Quinn M; Buckman D; Fang Y; Colcher D; King DJ; Bebbington C; Yarranton G
Cancer Immunol Immunother; 2002 Mar; 51(1):15-24. PubMed ID: 11845256
[TBL] [Abstract][Full Text] [Related]
20. Modulation of rat B cell differentiation in vivo by the administration of an anti-mu monoclonal antibody.
Soares M; Havaux X; Nisol F; Bazin H; Latinne D
J Immunol; 1996 Jan; 156(1):108-18. PubMed ID: 8598450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
